BioSpace News Archive

The global clinical decision support systems (CDSS) market is expected to reach USD 2,406.2 Million by 2027, according to a new report by Emergen Research.

The Global Minimally Invasive Biopsy Technologies Market is projected to reach USD 3.98 billion in 2027.

The global pharmacovigilance market is expected to be worth USD 12.48 Billion by 2027, according to a current analysis by Emergen Research.

The global viral vectors and plasmids manufacturing market is expected to reach USD 1.12 billion by 2027.

Latest Study on “Life Science Tools Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

Recent developments in the Company’s pipeline, collaborations, and operations, as well as financial results for the second quarter and first half 2022, are summarised below.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it has filed an amended complaint against Foresight Diagnostics.

Athersys, Inc. announced the closing of its previously announced registered direct offering with a single healthcare-focused U.S. institutional investor for the purchase of 48,000,000 shares of the Company’s common stock and warrants to purchase up to 48,000,000 shares of common stock at a combined purchase price of $0.25, resulting in gross proceeds of approximately $12 million before deducting placement agent fees and other offering expenses.

QuidelOrtho Corporation, a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced that its board of directors has authorized the repurchase of up to $300 million of shares of QuidelOrtho’s common stock over the next two years.